Peutz-Jeghers syndrome screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (20 intermediate revisions by 4 users not shown) | |||
| Line 2: | Line 2: | ||
{{Peutz-Jeghers syndrome}} | {{Peutz-Jeghers syndrome}} | ||
{{CMG}} {{AE}} {{ | {{CMG}}; {{AE}} {{HQ}} | ||
==Overview== | ==Overview== | ||
Screening for cancerous lesions by small intestine radiography, [[esophagogastroduodenoscopy]] (EGD), [[colonoscopy]], pancreatic [[ultrasound]], pelvic ultrasound, [[mammography]], and Papanicolaou (Pap) | Screening for [[cancerous]] lesions by [[small intestine]] [[radiography]], [[esophagogastroduodenoscopy]] ([[EGD]]), [[colonoscopy]], [[pancreatic]] [[ultrasound]], [[pelvic ultrasound]], [[mammography]], and [[Pap test|Papanicolaou test]] ([[Pap test]]) is recommended among patients with Peutz-Jeghers syndrome. | ||
==Screening== | ==Screening== | ||
Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the [[hamartomas]] by: | Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the [[hamartomas]] by:<ref name="SyngalBrand2015">{{cite journal|last1=Syngal|first1=Sapna|last2=Brand|first2=Randall E|last3=Church|first3=James M|last4=Giardiello|first4=Francis M|last5=Hampel|first5=Heather L|last6=Burt|first6=Randall W|title=ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes|journal=The American Journal of Gastroenterology|volume=110|issue=2|year=2015|pages=223–262|issn=0002-9270|doi=10.1038/ajg.2014.435}}</ref> | ||
*[[Genetic testing]] | *[[Genetic testing]] | ||
*[[Esophagogastroduodenoscopy|Upper GI endoscopy]] | *[[Esophagogastroduodenoscopy|Upper GI endoscopy]] | ||
*[[Enteroclysis]] | *[[Enteroclysis]] | ||
*[[Colonoscopy]] | *[[Colonoscopy]] | ||
== References == | == References == | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
[[Category:Oncology]] | |||
[[Category:Disease]] | |||
[[Category:Pediatrics]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 16:43, 21 December 2017
|
Peutz-Jeghers syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Peutz-Jeghers syndrome screening On the Web |
|
American Roentgen Ray Society Images of Peutz-Jeghers syndrome screening |
|
Risk calculators and risk factors for Peutz-Jeghers syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
Screening for cancerous lesions by small intestine radiography, esophagogastroduodenoscopy (EGD), colonoscopy, pancreatic ultrasound, pelvic ultrasound, mammography, and Papanicolaou test (Pap test) is recommended among patients with Peutz-Jeghers syndrome.
Screening
Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the hamartomas by:[1]
References
- ↑ Syngal, Sapna; Brand, Randall E; Church, James M; Giardiello, Francis M; Hampel, Heather L; Burt, Randall W (2015). "ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes". The American Journal of Gastroenterology. 110 (2): 223–262. doi:10.1038/ajg.2014.435. ISSN 0002-9270.